nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—HTR7—myenteric nerve plexus—colon cancer	0.0456	0.132	CbGeAlD
Asenapine—HTR7—vein—colon cancer	0.0294	0.0848	CbGeAlD
Asenapine—HTR2A—myenteric nerve plexus—colon cancer	0.0284	0.082	CbGeAlD
Asenapine—Sickness—Irinotecan—colon cancer	0.0232	0.0356	CcSEcCtD
Asenapine—HTR2A—vein—colon cancer	0.0183	0.0529	CbGeAlD
Asenapine—Hypoaesthesia oral—Capecitabine—colon cancer	0.0165	0.0253	CcSEcCtD
Asenapine—Localized exfoliation—Capecitabine—colon cancer	0.016	0.0245	CcSEcCtD
Asenapine—Parkinsonism—Fluorouracil—colon cancer	0.0136	0.0208	CcSEcCtD
Asenapine—UGT1A4—renal system—colon cancer	0.0132	0.0381	CbGeAlD
Asenapine—HTR1B—blood vessel—colon cancer	0.0121	0.0349	CbGeAlD
Asenapine—HTR1D—blood vessel—colon cancer	0.0117	0.0338	CbGeAlD
Asenapine—Akathisia—Irinotecan—colon cancer	0.0117	0.0178	CcSEcCtD
Asenapine—UGT1A4—digestive system—colon cancer	0.0108	0.0312	CbGeAlD
Asenapine—Sinus tachycardia—Capecitabine—colon cancer	0.0107	0.0164	CcSEcCtD
Asenapine—HTR7—endothelium—colon cancer	0.0101	0.0292	CbGeAlD
Asenapine—HTR7—blood vessel—colon cancer	0.00933	0.0269	CbGeAlD
Asenapine—Paraesthesia oral—Capecitabine—colon cancer	0.00921	0.0141	CcSEcCtD
Asenapine—Blister—Fluorouracil—colon cancer	0.00857	0.0131	CcSEcCtD
Asenapine—UGT1A4—liver—colon cancer	0.00807	0.0233	CbGeAlD
Asenapine—Hypertriglyceridaemia—Capecitabine—colon cancer	0.00752	0.0115	CcSEcCtD
Asenapine—Dysarthria—Irinotecan—colon cancer	0.00682	0.0104	CcSEcCtD
Asenapine—Ulcer—Irinotecan—colon cancer	0.00682	0.0104	CcSEcCtD
Asenapine—HRH2—digestive system—colon cancer	0.00679	0.0196	CbGeAlD
Asenapine—Blood triglycerides increased—Capecitabine—colon cancer	0.00659	0.0101	CcSEcCtD
Asenapine—Ulcer—Fluorouracil—colon cancer	0.00653	0.01	CcSEcCtD
Asenapine—Dysarthria—Fluorouracil—colon cancer	0.00653	0.01	CcSEcCtD
Asenapine—Pulmonary embolism—Irinotecan—colon cancer	0.00645	0.00988	CcSEcCtD
Asenapine—Inflammation—Fluorouracil—colon cancer	0.00637	0.00975	CcSEcCtD
Asenapine—HTR2A—endothelium—colon cancer	0.00631	0.0182	CbGeAlD
Asenapine—Salivary hypersecretion—Irinotecan—colon cancer	0.00627	0.00959	CcSEcCtD
Asenapine—Blister—Capecitabine—colon cancer	0.00599	0.00917	CcSEcCtD
Asenapine—Mouth ulceration—Vincristine—colon cancer	0.00599	0.00917	CcSEcCtD
Asenapine—HTR2A—blood vessel—colon cancer	0.00582	0.0168	CbGeAlD
Asenapine—HTR2B—smooth muscle tissue—colon cancer	0.00511	0.0147	CbGeAlD
Asenapine—Swelling—Fluorouracil—colon cancer	0.00508	0.00778	CcSEcCtD
Asenapine—HRH2—liver—colon cancer	0.00506	0.0146	CbGeAlD
Asenapine—Anaphylactoid reaction—Irinotecan—colon cancer	0.00484	0.00741	CcSEcCtD
Asenapine—Hyponatraemia—Vincristine—colon cancer	0.00483	0.00739	CcSEcCtD
Asenapine—Pain in extremity—Vincristine—colon cancer	0.00481	0.00736	CcSEcCtD
Asenapine—Hyponatraemia—Irinotecan—colon cancer	0.0047	0.0072	CcSEcCtD
Asenapine—Dermatitis bullous—Fluorouracil—colon cancer	0.00469	0.00718	CcSEcCtD
Asenapine—Osteoarthritis—Irinotecan—colon cancer	0.00468	0.00717	CcSEcCtD
Asenapine—Dysarthria—Capecitabine—colon cancer	0.00457	0.00699	CcSEcCtD
Asenapine—Ulcer—Capecitabine—colon cancer	0.00457	0.00699	CcSEcCtD
Asenapine—HTR7—epithelium—colon cancer	0.00454	0.0131	CbGeAlD
Asenapine—Osteoarthritis—Fluorouracil—colon cancer	0.00449	0.00687	CcSEcCtD
Asenapine—Inflammation—Capecitabine—colon cancer	0.00445	0.00681	CcSEcCtD
Asenapine—HTR1A—renal system—colon cancer	0.00441	0.0127	CbGeAlD
Asenapine—ADRA1A—epithelium—colon cancer	0.00438	0.0126	CbGeAlD
Asenapine—HTR7—smooth muscle tissue—colon cancer	0.00437	0.0126	CbGeAlD
Asenapine—Pulmonary embolism—Capecitabine—colon cancer	0.00432	0.00661	CcSEcCtD
Asenapine—Irritability—Fluorouracil—colon cancer	0.00428	0.00655	CcSEcCtD
Asenapine—Orthostatic hypotension—Irinotecan—colon cancer	0.00428	0.00655	CcSEcCtD
Asenapine—HTR7—renal system—colon cancer	0.00421	0.0121	CbGeAlD
Asenapine—Skin exfoliation—Capecitabine—colon cancer	0.00412	0.00631	CcSEcCtD
Asenapine—SLC6A4—digestive system—colon cancer	0.00407	0.0117	CbGeAlD
Asenapine—ADRA1A—renal system—colon cancer	0.00406	0.0117	CbGeAlD
Asenapine—HTR2B—digestive system—colon cancer	0.00403	0.0116	CbGeAlD
Asenapine—Mouth ulceration—Capecitabine—colon cancer	0.0039	0.00598	CcSEcCtD
Asenapine—Neutropenia—Vincristine—colon cancer	0.00389	0.00595	CcSEcCtD
Asenapine—HRH2—lymph node—colon cancer	0.00388	0.0112	CbGeAlD
Asenapine—Dysphagia—Fluorouracil—colon cancer	0.00388	0.00593	CcSEcCtD
Asenapine—ADRA2C—renal system—colon cancer	0.00387	0.0112	CbGeAlD
Asenapine—Neutropenia—Irinotecan—colon cancer	0.00379	0.00579	CcSEcCtD
Asenapine—Depression—Vincristine—colon cancer	0.0037	0.00566	CcSEcCtD
Asenapine—Stomatitis—Vincristine—colon cancer	0.00361	0.00553	CcSEcCtD
Asenapine—Diabetes mellitus—Capecitabine—colon cancer	0.0036	0.00552	CcSEcCtD
Asenapine—HTR2B—vagina—colon cancer	0.00356	0.0103	CbGeAlD
Asenapine—Swelling—Capecitabine—colon cancer	0.00355	0.00544	CcSEcCtD
Asenapine—Stomatitis—Irinotecan—colon cancer	0.00352	0.00538	CcSEcCtD
Asenapine—HTR2A—embryo—colon cancer	0.00347	0.01	CbGeAlD
Asenapine—HTR7—digestive system—colon cancer	0.00345	0.00996	CbGeAlD
Asenapine—Ulcer—Methotrexate—colon cancer	0.0034	0.0052	CcSEcCtD
Asenapine—Dysarthria—Methotrexate—colon cancer	0.0034	0.0052	CcSEcCtD
Asenapine—HRH1—epithelium—colon cancer	0.00339	0.00978	CbGeAlD
Asenapine—ADRA1A—lymphoid tissue—colon cancer	0.00337	0.00973	CbGeAlD
Asenapine—Stomatitis—Fluorouracil—colon cancer	0.00337	0.00516	CcSEcCtD
Asenapine—CYP1A2—renal system—colon cancer	0.00336	0.00969	CbGeAlD
Asenapine—Increased appetite—Capecitabine—colon cancer	0.00334	0.00511	CcSEcCtD
Asenapine—Inflammation—Methotrexate—colon cancer	0.00331	0.00507	CcSEcCtD
Asenapine—Dermatitis bullous—Capecitabine—colon cancer	0.00328	0.00502	CcSEcCtD
Asenapine—Connective tissue disorder—Vincristine—colon cancer	0.00327	0.005	CcSEcCtD
Asenapine—HRH1—smooth muscle tissue—colon cancer	0.00327	0.00942	CbGeAlD
Asenapine—Agranulocytosis—Fluorouracil—colon cancer	0.00323	0.00494	CcSEcCtD
Asenapine—Pulmonary embolism—Methotrexate—colon cancer	0.00321	0.00492	CcSEcCtD
Asenapine—Connective tissue disorder—Irinotecan—colon cancer	0.00318	0.00487	CcSEcCtD
Asenapine—Hyponatraemia—Capecitabine—colon cancer	0.00315	0.00482	CcSEcCtD
Asenapine—Osteoarthritis—Capecitabine—colon cancer	0.00313	0.0048	CcSEcCtD
Asenapine—Pain in extremity—Capecitabine—colon cancer	0.00313	0.0048	CcSEcCtD
Asenapine—Cardiac disorder—Vincristine—colon cancer	0.00309	0.00473	CcSEcCtD
Asenapine—Skin exfoliation—Methotrexate—colon cancer	0.00307	0.0047	CcSEcCtD
Asenapine—Angiopathy—Vincristine—colon cancer	0.00302	0.00462	CcSEcCtD
Asenapine—Cardiac disorder—Irinotecan—colon cancer	0.00301	0.0046	CcSEcCtD
Asenapine—Mediastinal disorder—Vincristine—colon cancer	0.003	0.00459	CcSEcCtD
Asenapine—Irritability—Capecitabine—colon cancer	0.00299	0.00458	CcSEcCtD
Asenapine—Angiopathy—Irinotecan—colon cancer	0.00294	0.0045	CcSEcCtD
Asenapine—Immune system disorder—Irinotecan—colon cancer	0.00293	0.00448	CcSEcCtD
Asenapine—Mediastinal disorder—Irinotecan—colon cancer	0.00292	0.00447	CcSEcCtD
Asenapine—Mental disorder—Vincristine—colon cancer	0.00291	0.00446	CcSEcCtD
Asenapine—Mouth ulceration—Methotrexate—colon cancer	0.00291	0.00445	CcSEcCtD
Asenapine—Gynaecomastia—Methotrexate—colon cancer	0.00288	0.0044	CcSEcCtD
Asenapine—Orthostatic hypotension—Capecitabine—colon cancer	0.00286	0.00438	CcSEcCtD
Asenapine—Breast disorder—Capecitabine—colon cancer	0.00283	0.00434	CcSEcCtD
Asenapine—HTR2A—epithelium—colon cancer	0.00283	0.00817	CbGeAlD
Asenapine—ADRA2C—vagina—colon cancer	0.0028	0.00809	CbGeAlD
Asenapine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00276	0.00423	CcSEcCtD
Asenapine—CYP1A2—digestive system—colon cancer	0.00275	0.00795	CbGeAlD
Asenapine—HTR2A—smooth muscle tissue—colon cancer	0.00273	0.00787	CbGeAlD
Asenapine—Muscle spasms—Irinotecan—colon cancer	0.00271	0.00415	CcSEcCtD
Asenapine—Dysphagia—Capecitabine—colon cancer	0.00271	0.00415	CcSEcCtD
Asenapine—Diabetes mellitus—Methotrexate—colon cancer	0.00268	0.00411	CcSEcCtD
Asenapine—Anaemia—Vincristine—colon cancer	0.00268	0.0041	CcSEcCtD
Asenapine—Agitation—Vincristine—colon cancer	0.00266	0.00407	CcSEcCtD
Asenapine—HTR2A—renal system—colon cancer	0.00263	0.00757	CbGeAlD
Asenapine—Anaemia—Irinotecan—colon cancer	0.00261	0.00399	CcSEcCtD
Asenapine—Abdominal discomfort—Capecitabine—colon cancer	0.0026	0.00398	CcSEcCtD
Asenapine—Leukopenia—Vincristine—colon cancer	0.00259	0.00397	CcSEcCtD
Asenapine—HRH1—digestive system—colon cancer	0.00258	0.00744	CbGeAlD
Asenapine—HTR7—liver—colon cancer	0.00257	0.00742	CbGeAlD
Asenapine—Malaise—Irinotecan—colon cancer	0.00254	0.00389	CcSEcCtD
Asenapine—Neutropenia—Capecitabine—colon cancer	0.00253	0.00388	CcSEcCtD
Asenapine—Syncope—Irinotecan—colon cancer	0.00253	0.00387	CcSEcCtD
Asenapine—Leukopenia—Irinotecan—colon cancer	0.00252	0.00386	CcSEcCtD
Asenapine—Convulsion—Vincristine—colon cancer	0.00251	0.00384	CcSEcCtD
Asenapine—Hypertension—Vincristine—colon cancer	0.0025	0.00383	CcSEcCtD
Asenapine—Anaemia—Fluorouracil—colon cancer	0.0025	0.00382	CcSEcCtD
Asenapine—ADRA1A—liver—colon cancer	0.00248	0.00716	CbGeAlD
Asenapine—Loss of consciousness—Irinotecan—colon cancer	0.00248	0.00379	CcSEcCtD
Asenapine—Weight increased—Capecitabine—colon cancer	0.00247	0.00377	CcSEcCtD
Asenapine—Hyperglycaemia—Capecitabine—colon cancer	0.00244	0.00374	CcSEcCtD
Asenapine—Hypertension—Irinotecan—colon cancer	0.00244	0.00373	CcSEcCtD
Asenapine—CYP3A4—renal system—colon cancer	0.00243	0.00701	CbGeAlD
Asenapine—Leukopenia—Fluorouracil—colon cancer	0.00242	0.0037	CcSEcCtD
Asenapine—Anaphylactoid reaction—Methotrexate—colon cancer	0.00241	0.00369	CcSEcCtD
Asenapine—Depression—Capecitabine—colon cancer	0.00241	0.00369	CcSEcCtD
Asenapine—CYP2D6—renal system—colon cancer	0.00239	0.0069	CbGeAlD
Asenapine—ADRA2C—liver—colon cancer	0.00236	0.00682	CbGeAlD
Asenapine—Anaphylactic shock—Vincristine—colon cancer	0.00236	0.00362	CcSEcCtD
Asenapine—Stomatitis—Capecitabine—colon cancer	0.00235	0.0036	CcSEcCtD
Asenapine—Convulsion—Fluorouracil—colon cancer	0.00234	0.00358	CcSEcCtD
Asenapine—Osteoarthritis—Methotrexate—colon cancer	0.00233	0.00357	CcSEcCtD
Asenapine—Nervous system disorder—Vincristine—colon cancer	0.00232	0.00355	CcSEcCtD
Asenapine—Thrombocytopenia—Vincristine—colon cancer	0.00231	0.00354	CcSEcCtD
Asenapine—HTR2B—lymph node—colon cancer	0.0023	0.00665	CbGeAlD
Asenapine—Anaphylactic shock—Irinotecan—colon cancer	0.0023	0.00352	CcSEcCtD
Asenapine—Hepatobiliary disease—Capecitabine—colon cancer	0.00228	0.0035	CcSEcCtD
Asenapine—HRH1—vagina—colon cancer	0.00228	0.00657	CbGeAlD
Asenapine—Shock—Irinotecan—colon cancer	0.00226	0.00347	CcSEcCtD
Asenapine—Nervous system disorder—Irinotecan—colon cancer	0.00226	0.00346	CcSEcCtD
Asenapine—Agranulocytosis—Capecitabine—colon cancer	0.00225	0.00345	CcSEcCtD
Asenapine—Thrombocytopenia—Irinotecan—colon cancer	0.00225	0.00345	CcSEcCtD
Asenapine—ADRA2A—vagina—colon cancer	0.00224	0.00645	CbGeAlD
Asenapine—Irritability—Methotrexate—colon cancer	0.00223	0.00341	CcSEcCtD
Asenapine—Hypotension—Vincristine—colon cancer	0.00221	0.00338	CcSEcCtD
Asenapine—Anaphylactic shock—Fluorouracil—colon cancer	0.0022	0.00337	CcSEcCtD
Asenapine—Nervous system disorder—Fluorouracil—colon cancer	0.00216	0.00331	CcSEcCtD
Asenapine—Thrombocytopenia—Fluorouracil—colon cancer	0.00216	0.0033	CcSEcCtD
Asenapine—HTR2A—digestive system—colon cancer	0.00215	0.00621	CbGeAlD
Asenapine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00215	0.0033	CcSEcCtD
Asenapine—Tachycardia—Fluorouracil—colon cancer	0.00215	0.00329	CcSEcCtD
Asenapine—Hypotension—Irinotecan—colon cancer	0.00215	0.00329	CcSEcCtD
Asenapine—Insomnia—Vincristine—colon cancer	0.00214	0.00327	CcSEcCtD
Asenapine—Oedema peripheral—Capecitabine—colon cancer	0.00214	0.00327	CcSEcCtD
Asenapine—Connective tissue disorder—Capecitabine—colon cancer	0.00213	0.00326	CcSEcCtD
Asenapine—Breast disorder—Methotrexate—colon cancer	0.00211	0.00323	CcSEcCtD
Asenapine—Insomnia—Irinotecan—colon cancer	0.00208	0.00319	CcSEcCtD
Asenapine—Hypotension—Fluorouracil—colon cancer	0.00206	0.00315	CcSEcCtD
Asenapine—CYP1A2—liver—colon cancer	0.00205	0.00592	CbGeAlD
Asenapine—Dyspnoea—Irinotecan—colon cancer	0.00205	0.00314	CcSEcCtD
Asenapine—Somnolence—Irinotecan—colon cancer	0.00205	0.00313	CcSEcCtD
Asenapine—Gastrointestinal disorder—Vincristine—colon cancer	0.00204	0.00312	CcSEcCtD
Asenapine—Fatigue—Vincristine—colon cancer	0.00204	0.00312	CcSEcCtD
Asenapine—Eye disorder—Capecitabine—colon cancer	0.00203	0.0031	CcSEcCtD
Asenapine—Dyspepsia—Irinotecan—colon cancer	0.00203	0.0031	CcSEcCtD
Asenapine—Constipation—Vincristine—colon cancer	0.00202	0.00309	CcSEcCtD
Asenapine—Cardiac disorder—Capecitabine—colon cancer	0.00201	0.00308	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00201	0.00307	CcSEcCtD
Asenapine—Insomnia—Fluorouracil—colon cancer	0.00199	0.00305	CcSEcCtD
Asenapine—CYP3A4—digestive system—colon cancer	0.00199	0.00575	CbGeAlD
Asenapine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00199	0.00304	CcSEcCtD
Asenapine—Fatigue—Irinotecan—colon cancer	0.00198	0.00304	CcSEcCtD
Asenapine—Constipation—Irinotecan—colon cancer	0.00197	0.00301	CcSEcCtD
Asenapine—Angiopathy—Capecitabine—colon cancer	0.00197	0.00301	CcSEcCtD
Asenapine—Dyspnoea—Fluorouracil—colon cancer	0.00197	0.00301	CcSEcCtD
Asenapine—CYP2D6—digestive system—colon cancer	0.00196	0.00566	CbGeAlD
Asenapine—Somnolence—Fluorouracil—colon cancer	0.00196	0.003	CcSEcCtD
Asenapine—Immune system disorder—Capecitabine—colon cancer	0.00196	0.003	CcSEcCtD
Asenapine—Mediastinal disorder—Capecitabine—colon cancer	0.00195	0.00299	CcSEcCtD
Asenapine—Dyspepsia—Fluorouracil—colon cancer	0.00194	0.00297	CcSEcCtD
Asenapine—Abdominal discomfort—Methotrexate—colon cancer	0.00193	0.00296	CcSEcCtD
Asenapine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.0019	0.00291	CcSEcCtD
Asenapine—HTR2A—vagina—colon cancer	0.0019	0.00549	CbGeAlD
Asenapine—Mental disorder—Capecitabine—colon cancer	0.0019	0.00291	CcSEcCtD
Asenapine—Malnutrition—Capecitabine—colon cancer	0.00189	0.00289	CcSEcCtD
Asenapine—Neutropenia—Methotrexate—colon cancer	0.00189	0.00289	CcSEcCtD
Asenapine—Dysgeusia—Capecitabine—colon cancer	0.00185	0.00283	CcSEcCtD
Asenapine—Muscle spasms—Capecitabine—colon cancer	0.00181	0.00278	CcSEcCtD
Asenapine—ADRA2C—lymph node—colon cancer	0.00181	0.00523	CbGeAlD
Asenapine—Depression—Methotrexate—colon cancer	0.00179	0.00274	CcSEcCtD
Asenapine—Tremor—Capecitabine—colon cancer	0.00177	0.00271	CcSEcCtD
Asenapine—Stomatitis—Methotrexate—colon cancer	0.00175	0.00268	CcSEcCtD
Asenapine—Anaemia—Capecitabine—colon cancer	0.00174	0.00267	CcSEcCtD
Asenapine—Hypersensitivity—Vincristine—colon cancer	0.00174	0.00267	CcSEcCtD
Asenapine—Malaise—Capecitabine—colon cancer	0.0017	0.00261	CcSEcCtD
Asenapine—Hepatobiliary disease—Methotrexate—colon cancer	0.0017	0.0026	CcSEcCtD
Asenapine—Hypersensitivity—Irinotecan—colon cancer	0.0017	0.0026	CcSEcCtD
Asenapine—Asthenia—Vincristine—colon cancer	0.0017	0.0026	CcSEcCtD
Asenapine—Syncope—Capecitabine—colon cancer	0.00169	0.00259	CcSEcCtD
Asenapine—Leukopenia—Capecitabine—colon cancer	0.00169	0.00259	CcSEcCtD
Asenapine—Agranulocytosis—Methotrexate—colon cancer	0.00168	0.00257	CcSEcCtD
Asenapine—Loss of consciousness—Capecitabine—colon cancer	0.00166	0.00254	CcSEcCtD
Asenapine—Asthenia—Irinotecan—colon cancer	0.00165	0.00253	CcSEcCtD
Asenapine—Hypertension—Capecitabine—colon cancer	0.00163	0.00249	CcSEcCtD
Asenapine—Hypersensitivity—Fluorouracil—colon cancer	0.00162	0.00249	CcSEcCtD
Asenapine—Arthralgia—Capecitabine—colon cancer	0.00161	0.00246	CcSEcCtD
Asenapine—HTR2A—liver—colon cancer	0.0016	0.00463	CbGeAlD
Asenapine—Anxiety—Capecitabine—colon cancer	0.0016	0.00245	CcSEcCtD
Asenapine—Dry mouth—Capecitabine—colon cancer	0.00157	0.00241	CcSEcCtD
Asenapine—Dizziness—Vincristine—colon cancer	0.00156	0.00239	CcSEcCtD
Asenapine—Dizziness—Irinotecan—colon cancer	0.00152	0.00233	CcSEcCtD
Asenapine—Shock—Capecitabine—colon cancer	0.00152	0.00232	CcSEcCtD
Asenapine—Nervous system disorder—Capecitabine—colon cancer	0.00151	0.00231	CcSEcCtD
Asenapine—Eye disorder—Methotrexate—colon cancer	0.00151	0.00231	CcSEcCtD
Asenapine—Thrombocytopenia—Capecitabine—colon cancer	0.00151	0.00231	CcSEcCtD
Asenapine—Tachycardia—Capecitabine—colon cancer	0.0015	0.0023	CcSEcCtD
Asenapine—Vomiting—Vincristine—colon cancer	0.0015	0.0023	CcSEcCtD
Asenapine—Cardiac disorder—Methotrexate—colon cancer	0.0015	0.00229	CcSEcCtD
Asenapine—Rash—Vincristine—colon cancer	0.00149	0.00228	CcSEcCtD
Asenapine—Dermatitis—Vincristine—colon cancer	0.00149	0.00228	CcSEcCtD
Asenapine—CYP3A4—liver—colon cancer	0.00149	0.00428	CbGeAlD
Asenapine—Headache—Vincristine—colon cancer	0.00148	0.00227	CcSEcCtD
Asenapine—HRH1—lymph node—colon cancer	0.00147	0.00425	CbGeAlD
Asenapine—Angiopathy—Methotrexate—colon cancer	0.00146	0.00224	CcSEcCtD
Asenapine—Vomiting—Irinotecan—colon cancer	0.00146	0.00224	CcSEcCtD
Asenapine—CYP2D6—liver—colon cancer	0.00146	0.00422	CbGeAlD
Asenapine—Immune system disorder—Methotrexate—colon cancer	0.00146	0.00223	CcSEcCtD
Asenapine—Dizziness—Fluorouracil—colon cancer	0.00146	0.00223	CcSEcCtD
Asenapine—Mediastinal disorder—Methotrexate—colon cancer	0.00145	0.00223	CcSEcCtD
Asenapine—Rash—Irinotecan—colon cancer	0.00145	0.00222	CcSEcCtD
Asenapine—Dermatitis—Irinotecan—colon cancer	0.00145	0.00222	CcSEcCtD
Asenapine—ADRA2A—lymph node—colon cancer	0.00145	0.00417	CbGeAlD
Asenapine—Headache—Irinotecan—colon cancer	0.00144	0.00221	CcSEcCtD
Asenapine—Hypotension—Capecitabine—colon cancer	0.00144	0.0022	CcSEcCtD
Asenapine—Mental disorder—Methotrexate—colon cancer	0.00141	0.00216	CcSEcCtD
Asenapine—Malnutrition—Methotrexate—colon cancer	0.00141	0.00215	CcSEcCtD
Asenapine—Nausea—Vincristine—colon cancer	0.0014	0.00215	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.0014	0.00215	CcSEcCtD
Asenapine—Vomiting—Fluorouracil—colon cancer	0.0014	0.00215	CcSEcCtD
Asenapine—Insomnia—Capecitabine—colon cancer	0.00139	0.00213	CcSEcCtD
Asenapine—Rash—Fluorouracil—colon cancer	0.00139	0.00213	CcSEcCtD
Asenapine—Dermatitis—Fluorouracil—colon cancer	0.00139	0.00213	CcSEcCtD
Asenapine—Headache—Fluorouracil—colon cancer	0.00138	0.00211	CcSEcCtD
Asenapine—Dysgeusia—Methotrexate—colon cancer	0.00138	0.00211	CcSEcCtD
Asenapine—Dyspnoea—Capecitabine—colon cancer	0.00137	0.0021	CcSEcCtD
Asenapine—Nausea—Irinotecan—colon cancer	0.00137	0.00209	CcSEcCtD
Asenapine—Dyspepsia—Capecitabine—colon cancer	0.00136	0.00208	CcSEcCtD
Asenapine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00133	0.00204	CcSEcCtD
Asenapine—Fatigue—Capecitabine—colon cancer	0.00133	0.00203	CcSEcCtD
Asenapine—Constipation—Capecitabine—colon cancer	0.00132	0.00202	CcSEcCtD
Asenapine—Nausea—Fluorouracil—colon cancer	0.00131	0.002	CcSEcCtD
Asenapine—Anaemia—Methotrexate—colon cancer	0.0013	0.00199	CcSEcCtD
Asenapine—Malaise—Methotrexate—colon cancer	0.00127	0.00194	CcSEcCtD
Asenapine—Leukopenia—Methotrexate—colon cancer	0.00126	0.00193	CcSEcCtD
Asenapine—Convulsion—Methotrexate—colon cancer	0.00122	0.00186	CcSEcCtD
Asenapine—Arthralgia—Methotrexate—colon cancer	0.0012	0.00183	CcSEcCtD
Asenapine—Anaphylactic shock—Methotrexate—colon cancer	0.00115	0.00176	CcSEcCtD
Asenapine—Hypersensitivity—Capecitabine—colon cancer	0.00114	0.00174	CcSEcCtD
Asenapine—Nervous system disorder—Methotrexate—colon cancer	0.00112	0.00172	CcSEcCtD
Asenapine—Thrombocytopenia—Methotrexate—colon cancer	0.00112	0.00172	CcSEcCtD
Asenapine—Asthenia—Capecitabine—colon cancer	0.00111	0.00169	CcSEcCtD
Asenapine—Hypotension—Methotrexate—colon cancer	0.00107	0.00164	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00104	0.0016	CcSEcCtD
Asenapine—Insomnia—Methotrexate—colon cancer	0.00104	0.00159	CcSEcCtD
Asenapine—Dyspnoea—Methotrexate—colon cancer	0.00102	0.00157	CcSEcCtD
Asenapine—Somnolence—Methotrexate—colon cancer	0.00102	0.00156	CcSEcCtD
Asenapine—Dizziness—Capecitabine—colon cancer	0.00102	0.00156	CcSEcCtD
Asenapine—Dyspepsia—Methotrexate—colon cancer	0.00101	0.00155	CcSEcCtD
Asenapine—Gastrointestinal disorder—Methotrexate—colon cancer	0.00099	0.00152	CcSEcCtD
Asenapine—Fatigue—Methotrexate—colon cancer	0.000989	0.00151	CcSEcCtD
Asenapine—Vomiting—Capecitabine—colon cancer	0.00098	0.0015	CcSEcCtD
Asenapine—Rash—Capecitabine—colon cancer	0.000971	0.00149	CcSEcCtD
Asenapine—Dermatitis—Capecitabine—colon cancer	0.00097	0.00149	CcSEcCtD
Asenapine—Headache—Capecitabine—colon cancer	0.000965	0.00148	CcSEcCtD
Asenapine—Nausea—Capecitabine—colon cancer	0.000915	0.0014	CcSEcCtD
Asenapine—Hypersensitivity—Methotrexate—colon cancer	0.000845	0.00129	CcSEcCtD
Asenapine—Asthenia—Methotrexate—colon cancer	0.000823	0.00126	CcSEcCtD
Asenapine—Dizziness—Methotrexate—colon cancer	0.000758	0.00116	CcSEcCtD
Asenapine—Vomiting—Methotrexate—colon cancer	0.000729	0.00112	CcSEcCtD
Asenapine—Rash—Methotrexate—colon cancer	0.000723	0.00111	CcSEcCtD
Asenapine—Dermatitis—Methotrexate—colon cancer	0.000722	0.00111	CcSEcCtD
Asenapine—Headache—Methotrexate—colon cancer	0.000718	0.0011	CcSEcCtD
Asenapine—Nausea—Methotrexate—colon cancer	0.000681	0.00104	CcSEcCtD
